Exchange: OTC·Updated 11:59 AM EST

GNIIF GNI Group Ltd.

$15.50
$0.97
(5.89%)
Today
EarningsNov 13
Mkt Cap$1.02B
Vol23,900.00

About GNIIF

GNI Group Ltd. engages in the development, research, manufacture, and sale of pharmaceutical drugs and traditional Chinese medicines. It operates through the following geographical segments: Pharmaceutical and Medical Device Business. The Pharmaceutical segment includes in IceLui, pharmaceutical development, other pharmaceuticals, reagents. The Medical Device segment designated manufacturer and distributor of biomaterials and medical devices, domestic clinical trial administrator services, fabrication of dental prosthetics, dental technology using CAD/CAM, and dental clinic consulting. The company was founded in November 2001 and is headquartered in Tokyo, Japan.
50

Sentiment

How do you feel about GNIIF?

Advertisement|Remove ads.